This is a biotech and it doesn’t matter how many shares are out there...Biotech companies run way better than any other company...BioClonetics is basically knocking on FDA’s door for approval on monoclonal antibodies Clone3 and ITV-1 haha... I’m just hoping it is at $0.05 ...company will be way higher once it goes current and they drop some updates on possible partnership with a big pharma co..